NCT06141577View on ClinicalTrials.gov

A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 8, 2023

Primary Completion Date

November 7, 2023

Study Completion Date

November 15, 2023

Conditions
GERD
Interventions
DRUG

UI059

take UI059 1cap/day for 7 days

DRUG

UIC202201

take UIC202201 1cap/day for 7 days

Trial Locations (1)

28644

Chungbuk national university hospital, Cheongju-si

All Listed Sponsors
lead

Korea United Pharm. Inc.

INDUSTRY

NCT06141577 - A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects | Biotech Hunter | Biotech Hunter